Evidence map›Paper›PMID 35919264›Full record

ArticleEuropean heart journal open2021

Association of clinical trial participation after myocardial infarction with socioeconomic status, clinical characteristics, and outcomes.

Joel Ohm, Tomas Jernberg, David Johansson, Anna Warnqvist, Margrét Leosdottir, Kristina Hambraeus, Per Svensson

Open access · goldAbstract read
In one paragraph

Article in European heart journal open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. UnfoldingEuropean heart journal open · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Joel OhmDepartment of Emergency Medicine, Solna, Karolinska University Hospital, Anna Steckséns gata 33, Stockholm SE-171 76, Sweden.ORCID https://orcid.org/0000-0001-6841-1904
Tomas JernbergDepartment of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm SE-18288, Sweden.
David JohanssonDepartment of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm SE-11883, Sweden.
Anna WarnqvistDivision of Biostatistics, Institute of Environmental Medicine, Nobels väg 13, Karolinska Institutet, Stockholm SE-17177, Sweden.
Margrét LeosdottirDepartment of Cardiology, Skåne University Hospital, Jan Waldenströms gata 15, Malmö SE-20502, Sweden.ORCID https://orcid.org/0000-0003-1677-1566
Kristina HambraeusDepartment of Cardiology, Falu Hospital, Lasarettsvägen, Falun SE-79182, Sweden.
Per SvenssonDepartment of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm SE-11883, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SEFalun Hospital · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To investigate whether participants in clinical trials after myocardial infarction (MI) are representable for the post-MI population concerning characteristics, secondary prevention, and prognosis. Methods and results: Cohort study on 31 792 attendants to 1-year revisits after MI throughout Sweden ( Conclusions: Clinical trial participants post-MI are more often male, have higher SES, a more advantageous risk profile, and better prognosis. Additional unmeasured participation bias was implied. Questionable external validity of post-MI trials highlights the importance of complementary studies using real-world data.

Indexed as

Evidence-based medicineMyocardial infarctionSecondary preventionSocioeconomic factors

Identifiers

PMID35919264
PMCPMC9241569
OpenAlexW3207205166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.